PROLONGED DUAL ANTIPLATELET THERAPY FOLLOWING DRUG-ELUTING STENT IMPLANTATION: MORE BLEEDING AND NO REDUCTION IN ISCHEMIC EVENTS-A META-ANALYSIS OF CLINICAL TRIALS

被引：1
|
作者：
El-Hayek, Georges [1 ]
Benjo, Alexandre [1 ]
Garcia, Daniel [1 ]
Hong, Mun [1 ]
Herzog, Eyal [1 ]
Tamis-Holland, Jacqueline [1 ]
机构：
[1] Columbia Univ, St Lukes Roosevelt Hosp Ctr, New York, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 63卷 / 12期
关键词：
D O I：
10.1016/S0735-1097(14)60097-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1151-228
引用
收藏
页码：A97 / A97
页数：1
相关论文
共 50 条
  • [31] Duration of dual antiplatelet therapy in patients with acute coronary syndrome undergoing drug-eluting stent implantation: A meta-analysis
    Geng, Xue
    Zhang, Ya-Nan
    Cui, Wei
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (04)
  • [32] The impact of dual antiplatelet therapy duration on primary composite endpoint after drug-eluting stent implantation: A meta-analysis of 10 randomized trials
    Pang, Si
    Shi, Shun-Yi
    Zhang, Yao-Jun
    Iqbal, Javaid
    Chen, Xiao-Yun
    Ren, Xiao-Min
    Zhu, Hao
    Zeng, Ya-Ping
    Bioh, Gabriel
    Bourantas, Christos V.
    Xu, Bo
    Serruys, Patrick W.
    Chen, Shao-Liang
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 202 : 504 - 506
  • [33] Addition of cilostazol to conventional dual antiplatelet therapy reducing the risk of cardiac events and restenosis after drug-eluting stent implantation: a meta-analysis
    Chen, Z. W.
    Qian, J. Y.
    Ma, J. Y.
    Ge, J. B.
    EUROPEAN HEART JOURNAL, 2012, 33 : 951 - 952
  • [34] Addition of Cilostazol to Conventional Dual Antiplatelet Therapy Reduces the Risk of Cardiac Events and Restenosis After Drug-Eluting Stent Implantation: A Meta-Analysis
    Chen, Zhangwei
    Qian, Juying
    Chen, Yinghua
    Ma, Jianying
    Ge, Junbo
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (05): : 532 - 539
  • [35] ADDITION OF CILOSTAZOL TO CONVENTIONAL DUAL ANTIPLATELET THERAPY REDUCING THE RISK OF CARDIAC EVENTS AND RESTENOSIS AFTER DRUG-ELUTING STENT IMPLANTATION: A META-ANALYSIS
    不详
    HEART, 2012, 98 : E203 - E203
  • [36] Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Sharma, Abhishek
    Garg, Aakash
    Elmariah, Sammy
    Drachman, Douglas
    Obiagwu, Chukwudi
    Vallakati, Ajay
    Sharma, Samin K.
    Lavie, Carl J.
    Mukherjee, Debabrata
    Waksman, Ron
    Stefanini, Giulio G.
    Feres, Fausto
    Marmur, Jonathan D.
    Helft, Gerard
    PROGRESS IN CARDIOVASCULAR DISEASES, 2018, 60 (4-5) : 500 - 507
  • [37] Dual antiplatelet therapy following drug-eluting stent implantation: how long is long enough?
    Ruparelia, Neil
    Chieffo, Alaide
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (06) : 585 - 587
  • [38] Benefit of Prolonged Dual Antiplatelet Therapy after Implantation of Drug-eluting Stent for Coronary Bifurcation Lesions
    Jang, Woo Jin
    Hahn, Joo-Yong
    Bin Song, Young
    Gwon, Hyeon-Cheol
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : B335 - B336
  • [39] No Benefit to Prolonged Dual Antiplatelet Therapy After Drug-Eluting Stent Placement
    Ebell, Mark H.
    AMERICAN FAMILY PHYSICIAN, 2014, 90 (07) : 502 - 502
  • [40] Duration of dual antiplatelet therapy and subsequent monotherapy type in patients undergoing drug-eluting stent implantation: a network Meta-analysis
    Benenati, Stefano
    Crimi, Gabriele
    Canale, Claudia
    Pescetelli, Fabio
    De Marzo, Vincenzo
    Vergallo, Rocco
    Galli, Mattia
    Della Bona, Roberta
    Canepa, Marco
    Ameri, Pietro
    Crea, Filippo
    Porto, Italo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N52 - N53
12345